Previous Article | Next Article 
Journal of Bacteriology, August 2000, p. 4401-4405, Vol. 182, No. 16
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Functional Characterization of the
HasAPF Hemophore and Its Truncated and Chimeric Variants:
Determination of a Region Involved in Binding to the Hemophore
Receptor
Sylvie
Létoffé,1
Kenji
Omori,2 and
Cécile
Wandersman1,*
Unité des Membranes Bactériennes,
Institut Pasteur (CNRS URA2172), 75724 Paris Cedex 15, France,1 and Discovery Research
Laboratory Tanabe, Seiyaku Co. Ltd., Osaka 532-8505, and Toda,
Saitama 335-8505, Japan2
Received 2 March 2000/Accepted 29 May 2000
 |
ABSTRACT |
Hemophores are secreted by several gram-negative bacteria
(Serratia marcescens, Pseudomonas aeruginosa,
Pseudomonas fluorescens, and Yersinia pestis)
and form a family of homologous proteins. Unlike the S. marcescens hemophore (HasASM), the P. fluorescens hemophore HasAPF has an additional region
of 12 residues located immediately upstream from the C-terminal
secretion signal. We show that HasAPF undergoes a
C-terminal cleavage which removes the last 21 residues when secreted
from P. fluorescens and that only the processed form is
able to deliver heme to the S. marcescens outer membrane
hemophore-specific receptor, HasRSM. Functional analysis of
variants including those with an internal deletion of the extra
C-terminal domain show that the secretion signal does not inhibit the
biological activity, whereas the 12-amino-acid region located upstream
does. This extra domain may inhibit the interaction of the hemophore
with HasRSM. To localize the hemophore regions involved in
binding to HasR, chimeric HasAPF-HasASM
proteins were tested for biological activity. We show that residues 153 to 180 of HasAPF are necessary for its interaction with the receptor.
 |
INTRODUCTION |
Bacteria have diverse high-affinity
heme uptake systems for the various heme sources that they might
encounter (3, 15). One such system is dependent on
hemophores which bind heme with high affinity and fulfill a function
similar to that of siderophores (2): they are secreted into
the extracellular medium, where they scavenge free or protein-bound
heme and then deliver it to a specific cell surface receptor. The
Serratia marcescens hemophore-dependent heme acquisition
system has been reconstituted in Escherichia coli
(5). Exogenously added S. marcescens hemophore
(HasASM) increases the efficiency of heme uptake via the
specific receptor (HasRSM) and also makes available new
heme sources (such as hemopexin and myoglobin) which are not recognized
by HasR alone (S. Létoffé et al., unpublished results). The
S. marcescens hemophore is a monomer which binds heme with a
stoichiometry of 1 and an affinity lower than 10
9 M
(8). The crystal structure of holoprotein has been solved and found to consist of a single module with two residues in
interaction with heme (1). Both heme-free and heme-loaded
hemophores bind to HasR with similar apparent affinities
(10
10 M), indicating direct protein-protein interactions
(10).
HasA-type hemophores are found in S. marcescens,
Pseudomonas aeruginosa (11), Pseudomonas
fluorescens (7), and Yersinia pestis
(J. M. Ghigo, personal communication) and form a family of
homologous proteins which do not share extensive similarity with any
other known proteins. They are secreted by ABC transporters in a
Sec-independent process (14). Like most proteins using this
pathway, they do not have an N-terminal signal sequence but rather have
an uncleavable C-terminal secretion sequence consisting of at least the
last 15 residues. This extreme C-terminal signal contains one or two
negatively charged residues followed by a hydrophobic stretch
(6). It is unstructured and highly accessible to the solvent
(16).
P. aeruginosa, P. fluorescens, and S. marcescens hemophores are secreted from E. coli by
their reconstituted ABC transporters. However, they have apparent
molecular weights higher than that of the proteins secreted by their
natural hosts. Mass spectrometry has shown a single cleavage of the
hemophore secreted from S. marcescens which removes the last
12 residues (9) and multiple cleavages of that from P. aeruginosa which remove 15 to 21 residues (11).
C-terminal cleavage is not required for secretion and presumably occurs
in the extracellular medium, a result of the activity of extracellular
proteases produced by S. marcescens and P. aeruginosa but not by E. coli. Both uncleaved and
cleaved HasASM and P. aeruginosa HasA
(HasAPA) bind heme and can acquire heme from hemoglobin.
Both forms of HasASM can deliver heme to the S. marcescens outer membrane receptor HasRSM in E. coli, allowing heme uptake. In a similar test performed with
HasPA, we found that the recombinant form of
HasAPA (uncleaved) cannot deliver heme to
HasRSM whereas the cleaved form can. HasAPA has
an additional region of 14 residues close to the C terminus not found
in HasASM but which is removed in the processed form
(11). We suggested that this additional domain close to the
C terminus could inhibit heme delivery by preventing a direct
interaction between HasRSM and HasAPA. However,
the occurrence of multiple cleavages of HasAPA in P. aeruginosa and the difficulty of separating the different processed forms complicate the study of the interaction between HasAPA and HasRSM.
Here, we found that HasAPF has properties very similar to
those of HasAPA: it is cleaved when secreted from P. fluorescens; both the processed and unprocessed forms bind heme,
whereas only the processed form can deliver heme to HasRSM.
However, unlike HasAPA, it undergoes a single cleavage in
P. fluorescens. This prompted us to construct variants of
HasAPF and HasAPF-HasASM chimeras
and to study their biological activity and binding to HasRSM to localize hemophore domains involved in binding to
HasRSM.
 |
MATERIALS AND METHODS |
Bacterial strains and plasmids.
E. coli C600
(F
thr leu fhuA lacY thi supE) and E. coli POP 3 hemA (araD139
lacU169
rpsL relA thi hemA) were from the laboratory collection.
P. fluorescens 33 was a gift from Haruo Kumura. pR10K carries hasRSM on pBGS18 (5). Plasmid
pSYC134 is pUC18 carrying hasASM, and pSYC150 is
pACYC184 carrying hasD and hasE (11). pFXF-HasA carries hasAPF, pFXM-HasA encodes the
HasAPF1-153-CterSM148-188, polypeptide, and
pFB
F-HasA encodes the HasAPF
181-192 polypeptide; they
are derived from pUC18 and described in reference 7.
Plasmid constructions.
pUC/HasAPF1-180-CterSM148-188 was created as
follows. A DNA fragment encoding amino acid residues 1 to 180 of
HasAPF was produced by inserting the phosphorylated
synthetic oligonucleotide linkers 5'-GATCTCTGCTGGGTTGGCCTGCA-3' and
5'-GGCCAACCCAGCAGA-3' between the BglII
and PstI sites of pUC18 encoding HasAPF,
resulting in pUC/HasAPF-PstI. The DNA fragment coding
for amino acid residues 148 to 188 of HasASM was generated
by PCR with the oligonucleotide 5'-GGGCTGCAGAGACCGCGCTGAACGGCATC-3', the universal primer M4
5'-GTTTTCCCAGTCACGAC-3', and pUC/HasASM as a
template DNA. The amplified fragment was digested with PstI
and BamHI and then introduced into the corresponding sites
of pUC18. The PstI-BamHI fragment of ca. 0.1 kb
was blunt ended and inserted between the PstI and
HindIII (blunt-ended) sites of
pUC/HasAPF-PstI. The resultant plasmid was digested with PstI, treated with T4 DNA polymerase, and then ligated to
destroy the PstI site, generating
pUC/HasAPF1-180-CterSM148-188.
The plasmid encoding a chimeric HasA protein consisting of residues 1 to 180 of HasAPF and residues 174 to 188 of
HasASM was created by inserting oligonucleotides. The PCR
product of ca. 0.1 kb amplified using the oligonucleotide
5'-GGGCATGCCGTGGGCGTGCAGCACGCC-3', the universal primer M4,
and a SphI-disrupted pUC/HasASM DNA was inserted
between the SphI and HindIII sites of
pUC/HasAPF. This plasmid was digested with BglII
and SphI and blunt ended with T4 polymerase, and the
oligonucleotides 5'-CGGCCAGGCCGGCCGA-3' and
5'-GATCTCGGCCGGCCTGGCCGCATG-3' were inserted, generating a plasmid encoding HasPF1-180-CterSM174-188. DNA
sequencing of the hybrid genes showed that the genetic manipulations
did not introduce any change in the hybrid protein amino acid
sequences. DNA manipulations were carried out according to standard
procedures (13).
Media.
All media and antibiotics were as described by Miller
(12). LBD contained 0.2 mM 2,2'-dipyridyl, to reduce iron
available to E. coli. LBD* contained 0.4 mM 2,2'-dipyridyl
to chelate iron in P. fluorescens cultures. Hemin,
hemin-agarose, and bovine hemoglobin was obtained from Sigma Chemical
Co. Bovine hemoglobin agar plates were prepared as described in
reference 5.
Protein analysis.
The HasAPF protein
secreted from E. coli was prepared from the
supernatant of an overnight culture (grown at 37°C in LBD) of C600
harboring plasmids encoding HasAPF (pFXF-HasA) and
HasSM transporter (pSYC150). The HasAPF protein
secreted from P. fluorescens was prepared from the
supernatant of P. fluorescens grown in LBD* at 23°C for
96 h. The supernatants were concentrated either by precipitation
with 10% trichloroacetic acid (TCA) (inactive supernatants) or by
ammonium sulfate precipitation: 60% for HasASM and 80%
for HasAPF (active supernatants).
Proteins in P. fluorescens active supernatant were purified
by hemin-agarose affinity chromatography as described previously. The
bound protein (as optical density [OD] equivalents) was eluted with
200 µl of the sample buffer for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or 200 µl of 6 M guanidine-HCl. The guanidine-eluted sample was incubated for 3 h at room
temperature on a wheel and then placed on an empty disposable column
with mesh to recover the eluted proteins. The elute was diluted with 200 µl of 0.2 M Tris-HCl (pH 7.5) and incubated overnight at 4°C on
a wheel. After dialysis against 10 mM Tris-HCl (pH 7.5), aliquots were
subjected to SDS-PAGE and stained with Coomassie blue to evaluate
protein concentration and purity, and other aliquots were used for
further experiments.
Amino acid sequence analysis.
N-terminal amino acid
sequences were determined using the G1005A protein sequencing system
(Hewlett-Packard).
Mass spectrometry.
The spectra of positive ions were
recorded in linear mode with a MALDI-TOF (matrix-assisted laser
desorption-ionization time-of-flight) mass spectrometer (Voyager
Elite; Perceptive Biosystems) using a saturated solution of sinapinic
acid (3,5-dimethoxy-4-hydroxycinnamic acid) in 30% acetonitrile as
matrix. External calibration was performed with apomyoglobin and
trypsinogen using the protonated ions of the monomer with average
m/z ratios of 16,952.6 and 23,983, respectively.
Electrophoresis and immunological techniques.
Proteins were
analyzed by SDS-PAGE followed either by Coomassie blue staining or
Western blot analysis. Coimmunoprecipitations were performed as
described previously (10). Anti-HasA and anti-HasR rabbit
polyclonal sera, both at a 1/5,000 dilution, were used for immunodetection.
E. coli growth assays on LBD hemoglobin agar plates
supplemented with purified HasA.
Growth stimulation of POP 3 hemA(pR10K) by exogenously supplied HasA was tested as
follows. Cells of the HasR-producing strain were mixed with 3 ml of top
agar and poured onto LBD plates supplemented with 10
6 M
hemoglobin (Hb-LBD). Five-millimeter-diameter wells were cut in the
agar and filled with 50 µl of serial dilutions of various HasA
preparations. Growth around the wells was recorded after overnight
incubation at 37°C (5).
 |
RESULTS AND DISCUSSION |
Characterization of the HasAPF proteins secreted by
P. fluorescens and by E. coli expressing the
HasSM transporter.
The supernatants were concentrated
by TCA precipitation, resolved by SDS-PAGE, and probed with
anti-HasASM antibodies. One protein band was detected in
each sample. The form secreted by E. coli exhibited a
molecular weight higher than that of the form secreted from P. fluorescens (data not shown). To determine the origin of the
difference in molecular weight, both forms (that secreted by P. fluorescens and that secreted by E. coli expressing the
HasSM transporter) were concentrated and purified by
hemin-agarose chromatography. Both forms bound heme (Fig.
1). The recombinant form had an apparent
molecular mass 3 kDa higher (Fig. 1). N-terminal amino acid sequencing
of the proteins purified on hemin-agarose showed sequences (TISVSEAA)
identical to the deduced amino acid sequence of HasAPF
(amino acid residues 2 to 10). Both lacked only the first methionine at
the N terminus. When analyzed by mass spectrometry, purified
HasAPF from the P. fluorescens culture gave one
major peak showing a molecular weight of 18,987.0. The value agreed
well with the calculated molecular weight of the monoprotonated
HasAPF composed of amino acid residues 2 to 185 (18,985.1).
Thus, HasAPF from the P. fluorescens
culture lacked also the 21 C-terminal residues (Fig.
2B).

View larger version (97K):
[in this window]
[in a new window]
|
FIG. 1.
Hemin-agarose chromatography of HasAPF
secreted from P. fluorescens and E. coli. Lane 1 (M), molecular weight markers. Lane 2 (U [unbound]) was loaded with 5 OD equivalents of concentrated P. fluorescens PF33
supernatant not bound to hemin-agarose. Lane 3 (B [bound]) was
loaded with hemin-bound material eluted by boiling in SDS-sample buffer
corresponding to 3 OD equivalents of ammonium sulfate-concentrated
supernatant. Lane 4 was loaded with 3 OD equivalents of
concentrated supernatant of E. coli strain
C600(pSYC150, pFXF-HasA) not bound to hemin-agarose. Lane 5 was loaded with hemin-bound material eluted by boiling in SDS-sample
buffer corresponding to 1.5 OD equivalents of ammonium
sulfate-concentrated supernatant. Samples were subjected to SDS-PAGE
(15% gel) followed by Coomassie brilliant blue G-250 staining.
|
|

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 2.
Chimeric HasA polypeptides. (A) Alignment of the amino
acid sequences of S. marcescens, P. aeruginosa,
and P. fluorescens HasA proteins. The residues are numbered
starting from the N-terminal methionine. However, mature
HasASM, HasAPA, and HasAPF
polypeptides lack the N-terminal methionine. The C-terminal proteolytic
cleavage sites in S. marcescens, P. aeruginosa,
and P. fluorescens are indicated by arrows. Bold characters
indicate identical residues in the three polypeptides. (B) Schematic
representation of HasAPF variants and
HasAPF-HasASM hybrid proteins. The solid and
open boxes represent amino acid sequences of HasASM and
HasAPF, respectively. The deletion of the region between
residues 180 and 193 of HasAPF (AHATATTTDVAL) is indicated
by a above the corresponding box. The C-terminal amino acid
sequences of the chimera are shown. The ability of each polypeptide to
stimulate growth of the HasRSM-producing strain is shown on
the right. The wells contained 2 to 10 µg of the HasAPF
wild-type and variant proteins. Similar growth stimulation was obtained
with 2 to 10 ng of HasASM. Growth around the wells was
recorded after overnight incubation at 37°C. +, bacterial growth ring
of 2 mm; +++, bacterial growth ring of 5 mm; , no growth.
|
|
Comparison of the biological activity of the recombinant and
processed HasAPF.
Growth stimulation of POP3
hemA(pR10K) by addition of serial dilutions of
concentrated HasAPF preparations was tested on
Hb-LBD. The unprocessed form did not show any growth stimulation,
whereas the processed form had significant activity (Fig. 2B). This
suggests that the 21 C-terminal residues interfere with the
heterologous complementation. The 14 C-terminal residues of this region
can promote (alone or fused to passenger proteins) efficient secretion via the HasSM transporter and therefore constitute the
secretion signal (7). This 14-amino-acid secretion signal is
well conserved in the three hemophores HasAPF,
HasASM, and HasAPA (Fig. 2A). In contrast, the
12 amino acids in HasAPF (from residues 181 to 192) located
just upstream from this secretion signal are absent from
HasASM (Fig. 2A). To determine whether the presence of this nonhomologous region was inhibiting the heterologous complementation, we tested a hasAPF variant (encoded by
pFB
F-HasA) consisting of an internally deleted protein in which the
N-terminal 180 amino acids are fused directly to the C-terminal
14 amino acids (HasAPF
181-192 [Fig. 2B])
(7). This construct lacks the extra 12-residue domain and is therefore similar to the active HasASM
produced by E. coli.
Biological activity of HasAPF
181-192.
The
HasAPF
181-192 variant was secreted by the
HasSM transporter (Fig. 3).
Added exogenously, this protein showed the same growth stimulation of
POP3 hemA(pR10K) as did the naturally processed protein on
Hb-LBD plates (Fig. 2B). Hence, the deletion of the 12 amino acids
restored biological activity in the heterologous complementation test,
indicating that it is not the secretion signal per se which blocks the
hemophore function.

View larger version (99K):
[in this window]
[in a new window]
|
FIG. 3.
Secretion of HasAPF chimeras and variants.
C600 carrying pSYC150 and the various pUC derivatives encoding the
HasAPF polypeptides were grown overnight. The proteins in
the culture supernatants were concentrated by TCA precipitation and
subjected to SDS-PAGE analysis. The gels were stained with Coomassie
brilliant blue G-250. Each lane was loaded with 3 OD equivalents of
concentrated supernatant.
|
|
As both the naturally processed form (at residue 185) and the
internally deleted variant lacking residues 181 to 192 are active, the
first 180 amino acids of HasAPF bear all of the
determinants required for heme binding and delivery to the receptor
HasRSM. To map more precisely the domain required for
heme delivery to HasRSM, we constructed chimeric
HasAPF having either the 153 or 180 N-terminal amino acids
of HasAPF fused to the 41-amino-acid C-terminal secretion
signal of HasASM.
Biological activity of chimeric
HasAPF-HasASM proteins.
HasAPF1-180-CterSM148-188 and
HasAPF1-153-CterSM148-188 were both efficiently
secreted by E. coli expressing the HasSM
transporter (Fig. 3). Both bound heme (data not shown). Only
HasAPF1-180-CterSM148-188 had activity in the
heterologous complementation test (Fig. 2B). The absence of biological
activity of the shorter HasAPF hybrid could be due to its
failure to interact with the receptor. As direct interactions between
HasRSM and HasASm have been previously demonstrated by coimmunoprecipitation (10), we used this
technique to determine the binding capacity of the two chimeras. Both
chimeras were immunoprecipitated with a monoclonal antibody directed
against the C-terminal 50 amino acids of HasASM. HasR was
detected only in the immunoprecipitate of the longer fusion (Fig.
4). This suggests that the
HasAPF residues 153 to 180 are required for the interaction between HasAPF and HasRSM. The
CterSM148-188 region shares 50% identity with the
corresponding region of HasAPF (Fig. 2A). However, the
inactivity of HasAPF1-153-CterSM148-188
indicated that the fusion did not lead to the reconstitution of a
functional binding domain. To confirm that the
CterSM148-188 domain does not contain the elements
necessary for binding, we tested the activity of a chimera with a
shorter CterSM of 15 amino acids.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 4.
Coimmunoprecipitation of HasA and HasR with a mouse
monoclonal anti-Cter-HasA antibody. Western blots were probed with
rabbit anti-HasA and anti-HasR antisera, both at a 1/5,000 dilution.
Approximately 40 OD culture equivalents of solubilized whole membrane
proteins were incubated with 10 µg of various HasAPF
polypeptides as indicated at the bottom. S, supernatant of the
immunoprecipitate (4 OD culture equivalents); P, immunoprecipitated
proteins (20 OD culture equivalents).
|
|
HasAPF1-180-CterSM174-188 was efficiently
secreted from E. coli by the HasSM transporter
(Fig. 3) and was active for heterologous complementation (Fig. 2B).
HasRSM was coimmunoprecipitated with this last chimera
(Fig. 4).
As HasASM residues 174 to 188 can be deleted without
changing the properties of HasA, the activity of
HasAPF1-180-CterSM174-188 is clearly not
dependent on the added HasASM domain. Thus, residues 153 to
180 of HasAPF are necessary for its biological activity and
in particular for its binding to the receptor. HasAPF
shares 41% identity with HasASM. This degree of similarity
all along the protein sequence suggests that the two proteins have
similar secondary and tertiary structures (4). The last 14 residues of the HasASM secretion signal are not seen in the
three-dimensional structure, and nuclear magnetic resonance
spectroscopy indicates that they are poorly structured (9).
The region located just upstream from the secretion signal forms two
helices (residues 144 to 155 and 167 to 174) on the side of the
globular HasA molecule opposite the heme pocket (1).
Similarly, the corresponding region of HasAPF, between
residues 144 and 180, is also likely to be on the opposite face of the
protein relative to the heme pocket. Possibly, recognition of the
heterologous receptor by HasAPF does not involve the heme
binding site but rather uses a C-terminal domain of the molecule
located upstream from the secretion signal.
We have identified a 12-amino-acid sequence (181 to 192) in
HasAPF located immediately upstream from the 14 C-terminal
secretion signal which is absent from HasASM and which
interferes with heterologous complementation (heme delivery via
HasAPF to HasRSM). The small size of the
inhibitory region suggests that it inhibits by masking the functionally
important neighboring domain (amino acids 150 to 180).
The physiological significance of the C-terminal cleavage that all
three studied hemophores undergo is unclear. The unprocessed and in
vitro processed forms of HasASM appear to have the same biological activity when exogenously added to S. marcescens
hemA or hasA mutants or to E. coli hemA
mutants expressing HasRSM (data not shown). Thus, the
inhibitory effect is revealed only in the heterologous systems.
Cleavage of the HasA C termini when secreted from their natural hosts
might simply be a consequence of their high accessibility to the
extracellular proteases also produced by these species.
 |
ACKNOWLEDGMENTS |
We are grateful to Philippe Delepelaire, Jean-Marc Ghigo, Laurent
Debarbieux, Pascal Arnoux, and Mirjam Czjzek for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité des
Membranes Bactériennes, Institut Pasteur (CNRS URA2172), 25 rue
du Dr. Roux, 75724 Paris Cedex 15, France. Phone: 33140613275. Fax:
33145688790. E-mail: cwander{at}pasteur.fr.
 |
REFERENCES |
| 1.
|
Arnoux, P.,
R. Haser,
N. Izadi,
A. D. Lecroisey,
C. Wandersman, and M. Czjzek.
1999.
The crystal structure of HasA, a hemophore secreted by Serratia marcescens.
Nature Struct. Biol.
6:516-520[CrossRef][Medline].
|
| 2.
|
Braun, V., and H. Killmann.
1999.
Bacterial solutions to the iron-supply problem.
Trends Biochem. Sci.
24:104-109[CrossRef][Medline].
|
| 3.
|
Cope, L.,
S. Thomas,
Z. Hrkal, and E. Hansen.
1998.
Binding of heme-hemopexin complexes by soluble HxuA protein allows utilization of this complexed heme by Haemophilus influenzae.
Infect. Immun.
66:4511-4516[Abstract/Free Full Text].
|
| 4.
|
Creighton, T.
1993.
The folded conformation of globular proteins. W. H.
Freeman and Company, New York, N.Y.
|
| 5.
|
Ghigo, J. M.,
S. Létoffé, and C. Wandersman.
1997.
A new type of hemophore-dependent heme acquisition system of Serratia marcescens reconstituted in Escherichia coli.
J. Bacteriol.
179:3572-3579[Abstract/Free Full Text].
|
| 6.
|
Ghigo, J. M., and C. Wandersman.
1994.
A carboxyl-terminal four-amino acid motif is required for secretion of the metalloprotease PrtG through the Erwinia chrysanthemi protease secretion pathway.
J. Biol. Chem.
269:8979-8985[Abstract/Free Full Text].
|
| 7.
|
Idei, A.,
E. Kawai,
H. Akatsuka, and K. Omori.
1999.
Cloning and characterization of the Pseudomonas fluorescens ATP binding cassette exporter, HasDEF, for the heme acquisition protein HasA.
J. Bacteriol.
181:7545-7551[Abstract/Free Full Text].
|
| 8.
|
Izadi, N.,
Y. Henri,
J. Haladjan,
M. E. Goldberg,
C. Wandersman,
M. Delepierre, and A. Lecroisey.
1997.
Purification and characterization of an extra cellular heme binding protein, HasA, involved in heme iron acquisition.
Biochemistry
36:7050-7057[CrossRef][Medline].
|
| 9.
|
Izadi-Pruneyre, N.,
N. Wolff,
V. Redeker,
C. Wandersman,
M. Delepierre, and A. Lecroisey.
1999.
NMR studies of the C-terminal secretion signal of the heme binding protein HasA.
J. Biochem.
261:562-568.
|
| 10.
|
Létoffé, S.,
F. Nato,
M. E. Goldberg, and C. Wandersman.
1999.
Interactions of HasA, a bacterial haemophore, with haemoglobin and with its outer membrane receptor HasR.
Mol. Microbiol.
33:546-555[CrossRef][Medline].
|
| 11.
|
Létoffé, S.,
V. Redeker, and C. Wandersman.
1998.
Isolation and characterisation of an extracellular heme binding protein from Pseudomonas aeruginosa that shares function and sequence similarities with the Serratia marcescens HasA hemophore.
Mol. Microbiol.
28:1223-1234[CrossRef][Medline].
|
| 12.
|
Miller, J. H.
1992.
A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 13.
|
Sambrook, J.,
F. Fritsch, and T. E. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 14.
|
Wandersman, C.
1998.
Protein and peptide secretion by ABC exporters.
Res. Microbiol.
149:163-170[Medline].
|
| 15.
|
Wandersman, C., and I. Stojiljkovic.
2000.
Bacterial heme sources: role of hemophores and receptors.
Curr. Opin. Microbiol.
3:215-220[CrossRef][Medline].
|
| 16.
|
Wolff, N.,
P. Delepierre,
J. Ghigo, and M. Delepierre.
1997.
Spectroscopic studies of the C-terminal secretion signal of the Serratia marcescens haem acquisition protein (HasA) in various membrane-mimetic environments.
Eur. J. Biochem.
15:400-407.
|
Journal of Bacteriology, August 2000, p. 4401-4405, Vol. 182, No. 16
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Caillet-Saguy, C., Turano, P., Piccioli, M., Lukat-Rodgers, G. S., Czjzek, M., Guigliarelli, B., Izadi-Pruneyre, N., Rodgers, K. R., Delepierre, M., Lecroisey, A.
(2008). Deciphering the Structural Role of Histidine 83 for Heme Binding in Hemophore HasA. J. Biol. Chem.
283: 5960-5970
[Abstract]
[Full Text]
-
Baysse, C., Matthijs, S., Schobert, M., Layer, G., Jahn, D., Cornelis, P.
(2003). Co-ordination of iron acquisition, iron porphyrin chelation and iron-protoporphyrin export via the cytochrome c biogenesis protein CcmC in Pseudomonas fluorescens. Microbiology
149: 3543-3552
[Abstract]
[Full Text]
-
Sapriel, G., Wandersman, C., Delepelaire, P.
(2002). The N Terminus of the HasA Protein and the SecB Chaperone Cooperate in the Efficient Targeting and Secretion of HasA via the ATP-binding Cassette Transporter. J. Biol. Chem.
277: 6726-6732
[Abstract]
[Full Text]
-
Rossi, M.-S., Fetherston, J. D., Letoffe, S., Carniel, E., Perry, R. D., Ghigo, J.-M.
(2001). Identification and Characterization of the Hemophore-Dependent Heme Acquisition System of Yersinia pestis. Infect. Immun.
69: 6707-6717
[Abstract]
[Full Text]